Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Croise-XT
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Croise-XT (also marketed as Croise-XT Power Syrup) is an oral nutritional supplement developed and marketed by Croise Pharma. It is formulated as a syrup containing ferrous ascorbate, folic acid (vitamin B9), cyanocobalamin (vitamin B12), and elemental zinc. It is primarily used as an iron supplement to treat or prevent low blood levels of iron (such as in iron-deficiency anemia or during pregnancy) and to address nutritional deficiencies in folate, vitamin B12, and zinc.
- Brand names
- Croise-XTCroise-XT Power Syrup
- Other names
- cyanocobalamin + ferrous ascorbate + folic acid + zinc
Beyond the preview
Go deeper on Croise-XT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Croise-XT.